Search

Your search keyword '"Roberts, Lewis R"' showing total 1,729 results

Search Constraints

Start Over You searched for: Author "Roberts, Lewis R" Remove constraint Author: "Roberts, Lewis R"
1,729 results on '"Roberts, Lewis R"'

Search Results

1. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.

3. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

4. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort

5. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

6. Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma

7. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

8. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis

10. Contributors

11. Development of a Computer-aided Prediction Tool for Evaluating Brushing Samples of Biliary Strictures

13. Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis

14. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression

16. Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

17. Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.

18. Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

19. Hepatocellular Carcinoma

20. Cholangiocarcinoma

21. Fibrolamellar Carcinoma

22. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

25. Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.

26. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

27. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis

28. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

29. AASLD guidelines for the treatment of hepatocellular carcinoma

32. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

33. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

34. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma

35. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response

40. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

41. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer

42. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

46. Children with Chronic Hepatitis B in the United States and Canada

47. Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

48. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso

49. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection

Catalog

Books, media, physical & digital resources